Clinical Effects of Translatoric Grades of Movement in Hip Osteoarthritis Patients

June 29, 2017 updated by: Elena Estebanez de Miguel, Universidad de Zaragoza

In orthopaedic manual therapy translatoric grades of movement are used to determine the intensity of force applied during the mobilization. Different clinical effects are described for each translatoric grade of movement but there are not published studies evaluating these clinical effects.

The objective of this trial is to determine if force magnitude during hip traction in resting position affects immediate and short-term outcomes (pain, physical function, hip muscle length and hip range of motion) in patients with hip osteoarthritis. For this purpose, investigators conduct a randomized clinical trial, double-blind (patient and physical therapist examiner). Participants entering the study were randomized into 1 of 3 treatment groups: grade I- grade IISZ mobilization, grade IITZ mobilization or grade III mobilization. Participants attend three sessions on alternate days (monday, wednesday, friday) and at the same hour. Measurements are taken prior to treatment, immediately after each session treatment.

The participants are recruited from physiotherapy groups or referred by general practitioners and orthopedic surgeons.

Participants were assigned to 1 of the 3 study groups through concealed allocation (sealed envelopes) and independent blocked randomization, using a random number generator.

One physical therapist enroll patients in the study, while an independent research assistant performed the randomization and prepared the sealed envelopes, which are opened after baseline data collection by the physiotherapist performing the treatments. Participants are treated in a private treatment area and have no knowledge of treatments received by other participants.

A second experienced orthopaedic manual therapist applies the standardized hip traction mobilization in resting position at either level of force, during 10 minutes. This amount of mobilization is consistent with clinical practice and previous studies in osteoarthritis patients.

Two physiotherapists (third and fourth) with 5 years of experience, who were blinded to participant group, performed all measurements.The outcome measures are pain, physical function, hip muscle length and hip passive range of motion. Pain is registered with visual analogic scale (VAS), Pressure Pain Threshold ( PPT) and WOMAC pain subscale. Physical function is registered using Timed Up & Go test (TUG), the 20-Meter Walking Test (20MWT) and the physical function subscale of WOMAC index. The hip muscle length is measured using Ely´s test, Active Knee Extension test and modified Ober´s test. The passive hip range of motion is measured using inclinometer or goniometer.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zaragoza, Spain, 50009
        • Elena Estebanez de Miguel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • unilateral primary hip OA according to the clinical criteria of the American College of Reumathology,
  • a grade III Kellgren & Lawrence (K-L) classification in their most recent hip X-rays,
  • mild to moderate pain from hip OA categorized using the WOMAC pain subscale (2 to 8 as mild pain; greater than 8 to 12 as moderate pain),
  • the ability to walk at least 20 meters, with or without an aid.

Exclusion Criteria:

  • neurological, vascular or other lower extremity musculoskeletal conditions that affected sensation, gait or functional performance,
  • contraindications for manual therapy
  • insufficient understanding of the Spanish language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Grade I-II SZ mobilization
Grade I-IISZ hip traction in resting position
Hip grade I-IISZ traction in a resting position is applied using gentle repetitive traction movements during 10 minutes. The mean peak force applied is 2,71N (S.D= 0,94), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.
Experimental: Grade II TZ mobilization
Grade IITZ hip traction in resting position
Hip grade IITZ traction in a resting position is applied during 10 minutes. The traction force is applied during 45 seconds with 15 seconds rest, until complete the 10 minutes of treatment. The mean peak force applied is 5.94 N (S.D= 1), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.
Experimental: Grade III mobilization
Grade III hip traction in resting position
Hip grade III traction in a resting position is applied during 10 minutes. The traction force is applied during 30 seconds with 30 seconds rest, until complete the 10 minutes of treatment. The mean peak force applied is 7.04 N (S.D= 0.32), according to previous study. Peak forces were measured using dynamometer and the therapist used it as a feedback to ensure mean peak force levels remain consistent.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pain on the VAS scale
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)
Pressure Pain Threshold (PPT)
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)
Pain on the pain subscale of WOMAC index (WOMAC-P)
Time Frame: pre-intervention and the next day of the last treatment session (baseline and 6 days)
pre-intervention and the next day of the last treatment session (baseline and 6 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Function on Timed Up & Go test (TUG)
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)
Physical Function on the 20-Meter Walking Test
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)
Physical Function on The physical function subscale of WOMAC index (WOMAC-PF)
Time Frame: pre-intervention and the next day of the last treatment session (baseline and 6 days)
pre-intervention and the next day of the last treatment session (baseline and 6 days)
Hip range of motion with digital inclinometer
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
Passive hip range of motion in the three planes is measured before and after each treatment sessions with a digital inclinometer
pre-intervention and post-intervention (baseline and 5 days)
Rectus femoris flexibility assessment: Ely´s test
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)
Hamstring flexibility assessment: Active Knee test
Time Frame: pre-intervention and post-intervention after each session (baseline and 5 days)
pre-intervention and post-intervention after each session (baseline and 5 days)
Iliotibial band tightness assessment: modified Ober´s test
Time Frame: pre-intervention and post-intervention (baseline and 5 days)
pre-intervention and post-intervention (baseline and 5 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elena Estebanez, PhD, Unidad de Investigación en Fisioterapia. Zaragoza, Zaragoza, Spain

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

July 8, 2015

First Submitted That Met QC Criteria

July 12, 2015

First Posted (Estimate)

July 15, 2015

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 29, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PI11/00061
  • PUZ/1 (Other Identifier: Universidad de Zaragoza)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on Grade I-II SZ mobilization

3
Subscribe